Tolvaptan

Trade Name: 
Jinarc
Manufacturer/Distributor: 
Otsuka Pharmaceuticals
Classification: 
Vasopressin V2-receptor antagonist
ATC Class: 
C03XA - Vaspopressin antagonist
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2015/02/02
Date Marketed in Canada (yyyy/mm/dd): 
2015/06/01
Presentation: 
Tablet: 45 mg. DIN: 02437503. Weekly blister pack of 45 + 15 mg.
Tablet: 60 mg. DIN: 02437511. Weekly blister pack of 60 + 30 mg.
Tablet: 90 mg. DIN: 02437538. Weekly blister pack of 90 + 30 mg.
Comments: 
Use to slow the progression of kidney enlargement in patients with autosomal dominant polycystic kidney disease.